Viewing Study NCT00066703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:42 PM
Ignite Modification Date: 2026-02-21 @ 11:35 PM
Study NCT ID: NCT00066703
Status: COMPLETED
Last Update Posted: 2025-03-26
First Post: 2003-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Sponsor: ETOP IBCSG Partners Foundation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II breast cancer View
None stage IIIA breast cancer View
None estrogen receptor-positive breast cancer View
None progesterone receptor-positive breast cancer View
None stage IA breast cancer View
None stage IB breast cancer View